Oil & Lubrication Analysis for Pharmaceutical Facilities

equipment modifications require change control and validation impact assessments; maintenance activities generate deviation investigations when they affect batch quality. In this environment, equipment failures cause batch deviations, product holds, FDA 483 observations, and consent decree risk. Our lubricant sampling and laboratory analysis program specifically targets HVAC air handling units, lyophilizers, tablet presses, centrifuges, clean utility systems (WFI, clean steam), and packaging lines — the assets where early detection has the greatest impact on batch success rate and deviation closure time. We also account for strict change control requirements, adapting our measurement approach to maintain data quality despite these operating conditions.

Yes. Pharmaceutical facilities must comply with FDA 21 CFR Parts 210/211 cGMP, EU Annex 15 qualification, and ISPE GAMP 5 for computerized systems. Our lubricant sampling and laboratory analysis program generates the condition documentation needed for cgmp-compliant maintenance documentation with audit trail, equipment qualification records, and calibration traceability. Beyond compliance, the condition data drives measurable improvements in batch success rate and deviation closure time by converting unplanned failures into scheduled repairs. Most pharmaceutical clients see meaningful reductions in batch deviations within the first 12 months of program implementation.

Pharmaceutical sites typically operate under FDA cGMP, EU Annex 15, ICH Q7. For Oil Analysis programs that translates into documentation requirements: traceable measurement records, calibrated instruments with audit certificates, written procedures aligned to ASTM D7720 (wear metals), ISO 4406 (cleanliness). The technical work is the same as any other industrial site, but the paper trail behind it is heavier. Plants new to regulated environments usually underestimate the documentation overhead by 20 to 30 percent.

Direct experience at Pharmaceutical sites is non-negotiable. Generic industrial Oil Analysis skills don't transfer cleanly to Pharmaceutical because of GMP validation, cleanroom equipment, batch traceability and the regulatory layer (FDA cGMP, EU Annex 15, ICH Q7). Ask for the lead analyst's hours of Pharmaceutical-specific work, certifications relevant to ASTM D7720 (wear metals), ISO 4406 (cleanliness), and references from comparable plants in the same industry segment. Vendor-provided references screen positive almost universally — call them directly.